Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00957424
Official study title

Acceptability of Less Harmful Alternatives to Cigarettes

Study summary

RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking. PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedtelephone-based intervention and nicotine replacement therapy

Plus 3 other study approaches.

Who it may be forBladder Cancer · Cervical Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 7, 2017 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Roswell Park Cancer Institute

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Interventional
Phase
Not applicable
Sponsor
Roswell Park Cancer Institute
Interventions being studied
Behavioral: telephone-based intervention; Drug: nicotine replacement therapy; Other: informational intervention; Other: internet-based intervention; Other: questionnaire administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • DISEASE CHARACTERISTICS:
  • Currently smokes ≥ 10 cigarettes per day
  • Not planning to quit smoking in the next 30 days and has not tried to quit in the past 30 days
  • Medically eligible to receive nicotine-replacement products, based on the NYS Smokers Quitline eligibility criteria PATIENT CHARACTERISTICS:
  • Not pregnant or nursing
  • Able to read and speak English
  • In good general health
  • No history of heart attack or stroke in the past 2 weeks
  • No history of chest pains in the past month
  • No report of physician-diagnosed arrhythmia/irregular heartbeat or use of pacemaker
  • No report of physician-diagnosed heart disease/coronary artery disease, uncontrolled hypertension, stomach ulcer, diabetes, depression, or asthma PRIOR CONCURRENT THERAPY:
  • No other concurrent tobacco products or nicotine medications
  • No concurrent Zyban, Bupropion, Wellbutrin, Chantix, or other smoking cessation medication

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Roswell Park Cancer InstituteBuffalo, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 7, 2017. Always confirm current availability with the study team.

View original record ↗